Pluri (PLUR) Other Gross PP&E Adjustments (2011 - 2025)
Pluri (PLUR) reported Other Gross PP&E Adjustments of -$6.6 million for Q4 2025, down 5.05% year-over-year from -$6.9 million in Q4 2024, and up 2.99% quarter-over-quarter from -$6.8 million in Q3 2025.
Pluri (PLUR) Other Gross PP&E Adjustments (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Other Gross PP&E Adjustments data on file, last reported at -$6.6 million in Q4 2025.
- Other Gross PP&E Adjustments for Q4 2025 came in at -$6.6 million, down 5.05% year-over-year; the trailing twelve-month figure through Dec 2025 was -$6.6 million (down 5.05% YoY), and the FY2025 annual result was $10.0 million, down 15.17% from the prior year.
- Other Gross PP&E Adjustments climbed to -$6.6 million in Q4 2025 per PLUR's latest filing, from -$6.8 million in the prior quarter.
- Over five years, Other Gross PP&E Adjustments peaked at $16.8 million in Q2 2021 and troughed at -$8.4 million in Q4 2021.
- A 5-year average of -$1.9 million and a median of -$6.7 million in 2025 frame the typical range for Other Gross PP&E Adjustments.
- The sharpest annual moves came in 2021 and 2022: Other Gross PP&E Adjustments soared 63.96% in 2021, then tumbled 1309.08% in 2022.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$8.4 million in 2021, then gained by 6.68% to -$7.9 million in 2022, then grew by 6.82% to -$7.3 million in 2023, then advanced by 15.04% to -$6.2 million in 2024, then dropped by 5.05% to -$6.6 million in 2025.
- Business Quant data shows PLUR's Other Gross PP&E Adjustments at -$6.6 million in Q4 2025, -$6.8 million in Q3 2025, and $10.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | -60,691.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -83,048.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -285.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -892,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | -1.69 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Pluri | 21.39 Mn | 21.87 Mn | 86,000.00 | -6.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.55 Mn |
| Dec 31, 2025 | -6.55 Mn |
| Sep 30, 2025 | -6.75 Mn |
| Sep 30, 2025 | -6.75 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Mar 31, 2025 | -7.03 Mn |
| Mar 31, 2025 | -7.03 Mn |
| Dec 31, 2024 | -6.24 Mn |
| Dec 31, 2024 | -6.24 Mn |
| Sep 30, 2024 | -6.40 Mn |
| Sep 30, 2024 | -6.40 Mn |
| Jun 30, 2024 | 11.83 Mn |
| Jun 30, 2024 | 11.83 Mn |
| Mar 31, 2024 | -7.15 Mn |
| Mar 31, 2024 | -7.15 Mn |
| Dec 31, 2023 | -7.34 Mn |
| Dec 31, 2023 | -7.34 Mn |
| Sep 30, 2023 | -7.47 Mn |
| Sep 30, 2023 | -7.47 Mn |